T, G. O., A, M., M, B., A, S., SE, K., CL, H., . . . T, T. (2026). Lomentospora prolificans osteomyelitis and septic arthritis in an immunocompromised patient, requiring transhumeral amputation and use of the novel antifungal olorofim. JSES reviews, reports, and techniques, 6(2), 100698. https://doi.org/10.1016/j.xrrt.2026.100698
Chicago Style (17th ed.) CitationT, G O'Donnell, MacPhail A, Blaser M, Seenarain A, Kidd SE, Halliday CL, Meher-Homji Z, and Tran T. "Lomentospora Prolificans Osteomyelitis and Septic Arthritis in an Immunocompromised Patient, Requiring Transhumeral Amputation and Use of the Novel Antifungal Olorofim." JSES Reviews, Reports, and Techniques 6, no. 2 (2026): 100698. https://doi.org/10.1016/j.xrrt.2026.100698.
MLA (9th ed.) CitationT, G O'Donnell, et al. "Lomentospora Prolificans Osteomyelitis and Septic Arthritis in an Immunocompromised Patient, Requiring Transhumeral Amputation and Use of the Novel Antifungal Olorofim." JSES Reviews, Reports, and Techniques, vol. 6, no. 2, 2026, p. 100698, https://doi.org/10.1016/j.xrrt.2026.100698.